Literature DB >> 8195144

Human acylpeptide hydrolase. Studies on its thiol groups and mechanism of action.

A Scaloni1, D Barra, W M Jones, J M Manning.   

Abstract

The presence of a cysteine residue(s) near the active site of acylpeptide hydrolase was suggested by inactivation of the enzyme with sulfhydryl-modifying agents and by the substantial protection against inactivation afforded by the competitive inhibitor acetylmethionine. 5,5'-dithiobis-(2-nitrobenzoate) titrations of the native and the denatured enzyme together with analysis for cysteic acid after performic acid oxidation showed that the enzyme contained 12 free SH groups and three disulfide bonds/monomer. Chemical modification with radiolabeled iodoacetamide led to the labeling of Cys-30 and Cys-64 suggesting that one or both of these Cys residues are close to the active site. Modification of one or both of them probably inhibits the enzyme either because of a distortion of the active site or because the adducts present a barrier to the efficient diffusion of substrates into and products out of the active site. Studies on the mechanism of action of acylpeptide hydrolase have employed p-nitrophenyl-N-propyl carbamate as a potent active site-directed inhibitor. Enzyme inactivation, which follows pseudo first-order kinetics, is diminished by the competitive inhibitor acetylmethionine. The inhibited enzyme slowly regains activity at a rate that is increased in the presence of the nucleophile hydroxylamine. A general mechanism involving an acyl-enzyme intermediate is supported by evidence for the formation of acetyl-alanyl hydroxamate during hydrolysis of acetyl-alanine p-nitroanilide in the presence of hydroxylamine. The effect on Vmax and Km during this reaction indicate that hydrolysis of the acyl-enzyme intermediate is rate-limiting.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8195144

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Observation of Clinically Relevant Drug Interaction in Chimeric Mice with Humanized Livers: The Case of Valproic Acid and Carbapenem Antibiotics.

Authors:  Eiko Suzuki; Kumiko Koyama; Daisuke Nakai; Ryoya Goda; Hiroshi Kuga; Kan Chiba
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-12       Impact factor: 2.441

2.  Assessing biomarkers and neuropsychological outcomes in rural populations exposed to organophosphate pesticides in Chile--study design and protocol.

Authors:  Muriel Ramírez-Santana; Liliana Zúñiga; Sebastián Corral; Rodrigo Sandoval; Paul T J Scheepers; Koos Van der Velden; Nel Roeleveld; Floria Pancetti
Journal:  BMC Public Health       Date:  2015-02-10       Impact factor: 3.295

3.  Acyl peptide hydrolase degrades monomeric and oligomeric amyloid-beta peptide.

Authors:  Rina Yamin; Cheng Zhao; Peter B O'Connor; Ann C McKee; Carmela R Abraham
Journal:  Mol Neurodegener       Date:  2009-07-23       Impact factor: 14.195

4.  Protoporphyrin IX enhancement by 5-aminolaevulinic acid peptide derivatives and the effect of RNA silencing on intracellular metabolism.

Authors:  L Bourré; F Giuntini; I M Eggleston; M Wilson; A J MacRobert
Journal:  Br J Cancer       Date:  2009-02-24       Impact factor: 7.640

5.  Identification of oxidized protein hydrolase as a potential prodrug target in prostate cancer.

Authors:  Christopher A McGoldrick; Yu-Lin Jiang; Victor Paromov; Marianne Brannon; Koyamangalath Krishnan; William L Stone
Journal:  BMC Cancer       Date:  2014-02-10       Impact factor: 4.430

Review 6.  Human carboxylesterases: a comprehensive review.

Authors:  Dandan Wang; Liwei Zou; Qiang Jin; Jie Hou; Guangbo Ge; Ling Yang
Journal:  Acta Pharm Sin B       Date:  2018-06-25       Impact factor: 11.413

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.